A website (http://www.mcgill.ca/pahdb ) is maintained by the curators for a Consortium (88 investigators, 28 countries) and all other users; it serves a relational database for human locus-specific genetic variation in a defined DNA sequence (GenBank U49897); (100 kb on human chromosome 12q24.1, gene symbol PAH). The intragenic nucleotide variation is both rare (Q < 0.01), extensive (>320 different mutations) and phenotype modifying, causing hyperphenylalaninemia by impairing phenylalanine hydroxylase function (see OMIM 261600), as well as polymorphic and neutral, the latter providing informative locus-specific haplotypes (>1200 different mutation/haplotye associations). The PAH database contains both offline core components (mutations, population associations and data source information) and several accessory online components: (i) relative frequencies of mutations by populations/regions (expanding file); (ii) data on genotypephenotype correlations both in vitro and in vivo (new file); (iii) polymorphic haplotype structures (new file); (iv) intron sequence data (new file for design of primers); (v) description of mouse homologues (new file for mutations and phenotypes); (vi) the predicted PAH gene mutability profile (improved graphic); (vii) a clinical field for patient use (new interface with database). The website home page has been revised and a counter is recording >15 visits per day. Linkages to other mutation databases and an alliance of mutation database curators (new) are expanding. The primary 'electronic publication' reports now vastly exceed print reports. PAHdb serves as a prototype for obtaining, storing and distributing records of human genetic variation.
INTRODUCTION
The original report (1) described a locus-specific relational database for mutations both phenotype-modifying and neutral polymorphic, and for accessory information at the human phenylalanine hydroxylase locus (symbol PAH). The present report describes improvements and developments in the database and its website.
Overview
The PAH relational database receives input from Consortium members and others; it has an architecture; output (accessible content) is in various forms (Fig. 1 ).
Input. Data are received from Consortium members (listed in database), from non-members or are retrieved from print publications; reports submitted directly to the database (electronic publications) now far exceed PAH mutation reports in print. All entries are dated, verified and credited. The database is sheltered offline and can be accessed only by the curators.
The Consortium itself has evolved and currently comprises 88 members in 28 countries. They and others have reported >320 different mutations (objects) in >1200 different associations with polymorphic haplotypes, populations and geographic regions; the mutations have been identified on >4400 mutant chromosomes worldwide.
Architecture and software. The database contains core and accessory tables. The software is Microsoft FoxPro version 2.6 for Windows. Small programs can be written in FoxPro for maintenance. Reports are generated automatically in HTML format as the fixed link between database and website. The latter resides on a UNIX machine (Sun Microsystems) running the Solaris 2.4 operating system. We recommend Netscape Navigator 3.0 or Microsoft Explorer 3.0 to view web pages and Adobe Acrobat Shareware to access more complex graphics.
Output. In addition to the (biannual) Newsletter, output is deposited on the Website (http://www.mcgill.ca/pahdb ). The revised human PAH cDNA reference sequence was also deposited (GenBank U49897). Linkages have been created with OMIM, and with 'central' (federated) human mutation databases (e.g. HGMD). The PAH mutation database can serve a wide range of 'clients' ( 
INNOVATIONS AND CHANGES
The following changes were introduced in the past year.
Nomenclature
Trivial names (single letter amino acid code and codon number) for mutations (e.g. R408W) are the convention in the Consortium; they are accompanied by the corresponding nucleotide change (e.g. CGG/TGG). The corresponding systematic name (e.g. c1222C→T) now appears for each mutation in the database. Nomenclature is in keeping with current recommendations (2-5), and will facilitate communication across databases.
Search engine
Core components are off line; copies are put on the Internet. A search engine for online inquiry is being developed in PERL and will run on a UNIX platform. Until now, searchable data were distributed on disk with a stand alone software package. The disk has not been updated since January 1996, but all entries will soon be retrievable by the Internet search engine.
Polymorphic haplotypes
The PAH gene has a rich array of informative diallelic and multiallelic intragenic polymorphic markers. The relative position of these markers is shown in a graphic and a table of haplotypes has been deposited in the database (by S. Byck).
Intron sequences
The full genomic sequence for PAH remains incomplete; the reference sequence (GenBank U49897) describes only the cDNA. Nucleotide sequences, including polymorphisms, extending further into introns than previously described (6) have been submitted (by E. Svensson and L. Hagenfeldt, Karolinska Institute) or are available on request from J. Horst and B. Dworniczak (see Consortium for address). They are deposited to assist primer design.
Mutability profile
Predicted mutability, codon by codon across the PAH gene, was analyzed with the MUTPRED software (7); the corresponding graphic display was developed and deposited (by K. Carter).
Genotype-phenotype correlations
Knowledge of genotypes influences prognosis and treatment of the variant phenotype. Data on 367 patients harbouring 161 different genotypes derived from 73 different mutations were deposited (by E. Kayaalp). Microsoft Excel spreadsheets and MS Word files summarize: (i) the primary sources (31 reports); (ii) phenotypes [phenylketonuria (PKU); variant PKU and non PKU 
Clinical field/interface
In response to suggestions from patients and a Consortium member (R. Eisensmith, USA), clinical text was developed and deposited (by Piotr Nowacki). It describes relevant issues in mutation detection and clinical management of the hyperphenylalaninemias. Visitors can interact with the field and make inquiries. This initiative parallels the prototype at the BRCA1 website.
Mouse homologs
A file describes the homologous mouse gene (symbol Pah), mutations there causing hyperphenylalaninemia in mice (8) , and the corresponding inbred strains of mice and phenotypes; (developed and deposited by C. Sarkissian and D. McDonald).
Linkages
The PAH mutation database is now linked (by pointer) to OMIM (entry 261600), GenBank (U49897) and a central (federated) mutation database (D. Cooper and M. Krawczak: http://www.cf.ac.uk/uwcm/mg/hgmd0.html ).
Other developments
The homepage has been modified (Fig. 2) ; a counter maintains an inventory of visits and visitors to the website (>15 per day); a small survey instrument solicits advice and comment.
COMMENT
The PAH mutation database and website have been put to a variety of usages. Several investigators are enumerating and comparing PAH mutations in defined regions and populations. Population genetic variation can be recorded and analyzed using both the polymorphic haplotype markers and the rare disease-producing allelic variation. Linkage with central databases will permit PAH alleles to be compared with those at other loci, and with those in the human genome as a whole. Mutation processes (e.g. recurrent or recombinant) can be postulated and analyzed. The biological significance of PAH mutations will be ascertained better from the growing body of data on genotypes and phenotypes. The database is a new Internet resource to inform families of developments in the management of its related diseases. Accordingly, this particular mutation database serves patients, clinicians, epidemiologists, population and molecular biologists, students, and perhaps business interests among others (Fig. 1) .
